Gujarat Themis Biosyn informs about outcome of analyst meet

27 Sep 2022 Evaluate

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’) read with part A of Schedule III of the Listing Regulations, Gujarat Themis Biosyn has informed that the management of the Company had calls/meetings with Analysts/Investors on Monday, 26th September, 2022; the details of the same are enclosed. No Unpublished Price Sensitive Information (UPSI) was discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company: www.gtbl.in

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

391.30 1.15 (0.29%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×